Incorrect Packaging Leads To Recall of Birth Control Pill

Incorrect Packaging Leads To Recall of Birth Control Pill

Introduction

On March 4, the FDA advised a nationwide birth control pill recall by Apotex Corp. impacting four lots of Drospirenone and Ethinyl Estradiol tablets, which may have placebo pills in the wrong area or missing tablets.

The recalled birth control pill packs might contain defective blisters with wrong tablet arrangements or empty blister pocket. This might lead the women to take tablets in the wrong order, lowering the effectiveness in preventing pregnancy. The FDA officials warned women need not discontinue taking birth control pills; however, they should follow a non-hormonal method of birth control too, while on the pills. The recall affected packs of tablets with lot numbers, 7DY008A,7DY009A, 7DY010A, and 7DY011A with NDC number 60505-4183-3 on the outer carton. The expiration date is listed as 8/2020.

The pills were manufactured by Oman Pharmaceutical Products, Co. LLC. and distributed by Apotex Corp. According to Apotex, no case of unintended pregnancy was reported.